Pharmacogenetics of aspirin-intolerant asthma

Author： Kim Seung-Hyun Hur Gyu-Young Choi Jeong-Hee Park Hae-Sim

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.9, Iss.1, 2008-01, pp. : 85-91

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Role of expression of prostaglandin synthases 1 and 2 and leukotriene C₄ synthase in aspirin-intolerant asthma: a theoretical study

By Dobovišek A. Fajmut A. Brumen M.

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 38, Iss. 2, 2011-04 ,pp. : 261-278

Springer Publishing Company

Access to resources Recommend Favorite

CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients

By Kim Seung-Hyun Ye Young-Min Hur Gyu Young Lee Soo-Keol Sampson Anthony P Lee Hyun-Young Park Hae-Sim

Pharmacogenomics, Vol. 8, Iss. 9, 2007-09 ,pp. : 1143-1150

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of the Antiplatelet Effect of Aspirin

Current Pharmaceutical Design, Vol. 18, Iss. 33, 2012-11 ,pp. : 5294-5308

Bentham Science Publishers

Access to resources Recommend Favorite

The Pharmacogenetics of Asthma Therapy

Current Drug Targets, Vol. 7, Iss. 12, 2006-01 ,pp. : 1697-1708

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of Asthma Therapy

Current Pharmaceutical Design, Vol. 15, Iss. 32, 2009-11 ,pp. : 3742-3753

Bentham Science Publishers

Access to resources Recommend Favorite